Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 7/20 | 0.61 |
| ▸ | GAA | P10253 | 9/20 | 0.58 |
| ▸ | MGAM | O43451 | 7/20 | 0.58 |
| ▸ | AMY1A | P0DUB6 | 7/20 | 0.58 |
| ▸ | SI | P14410 | 7/20 | 0.58 |
| ▸ | MGAM2 | Q2M2H8 | 7/20 | 0.58 |
| ▸ | RAB9A | P51151 | 6/20 | 0.58 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29479841 | 1.00 | SLC9A1 (0.61) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL11500266 | 0.84 | GAA (0.64) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL21678019 | 0.83 | EGLN3 (0.65) | SLC9A1GAARAB9ANPC1SMN1; SMN2 | |
| SCHEMBL21845212 | 0.83 | SLC9A1 (0.62) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL1689837 | 0.83 | GAA (0.67) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL16578183 | 0.82 | SLC9A1 (0.56) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL17895674 | 0.80 | GAA (0.63) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL13821381 | 0.79 | GAA (0.66) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL29625506 | 0.77 | GAA (0.73) | SLC9A1GAAMGAMAMY1ASI | |
| SCHEMBL361654 | 0.77 | GAA (0.73) | SLC9A1GAAMGAMAMY1ASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4097155-B1 | ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF | CLEARLAB SG PTE LTD (SG) | 2025-08-20 | — | — | EP | disclosed |
| US-20250007001-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2025-01-02 | — | — | US | disclosed |
| US-20240250306-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2024-07-25 | — | — | US | disclosed |
| US-12037463-B2 | Antimicrobial ophthalmic devices comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2024-07-16 | — | — | US | disclosed |
| US-12024597-B2 | Wound dressings comprising polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2024-07-02 | — | — | US | disclosed |
| WO-2023170799-A1 | LITHIUM SECONDARY BATTERY | ＴｅｒａＷａｔｔ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 2023-09-14 | — | — | WO | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230261203-A1 | LITHIUM SECONDARY BATTERY | TERAWATT TECHNOLOGY K.K. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230227613-A1 | ANTIMICROBIAL OPHTHALMIC DEVICES COMPRISING POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF | CLEARLAB SG PTE LTD (SG) | 2023-07-20 | — | — | US | disclosed |
| US-20230212357-A1 | WOUND DRESSINGS COMPRISING POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF | CLEARLAB SG PTE LTD (SG) | 2023-07-06 | — | — | US | disclosed |
| US-11649325-B2 | Actinically-crosslinkable polysiloxane-polyglycerol block copolymers and methods of making and use thereof | Clearlab Sg Pte Ltd. (SG) | 2023-05-16 | — | — | US | disclosed |
| WO-2023053295-A1 | LITHIUM SECONDARY BATTERY | ＴｅｒａＷａｔｔ Ｔｅｃｈｎｏｌｏｇｙ株式会社 | 2023-04-06 | — | — | WO | disclosed |
| US-20210246270-A1 | ACTINICALLY-CROSSLINKABLE POLYSILOXANE-POLYGLYCEROL BLOCK COPOLYMERS AND METHODS OF MAKING AND USE THEREOF | Clearlab Sg Pte Ltd. (SG) | 2021-08-12 | — | — | US | disclosed |
| EP-2721019-B1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE | AGIOS PHARMACEUTICALS INC (US) | 2018-08-08 | — | — | EP | disclosed |
| US-8330039-B2 | Solar cell modules with poly(vinyl butyral) encapsulant comprising unsaturated heterocyclic compound | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-12-11 | — | — | US | disclosed |
| EP-2380208-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. du Pont de Nemours and Company (US) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010085664-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-29 | — | — | WO | disclosed |
| US-20100180947-A1 | SOLAR CELL MODULES WITH POLY(VINYL BUTYRAL) ENCAPSULANT COMPRISING UNSATURATED HETEROCYCLIC COMPOUND | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-07-22 | — | — | US | disclosed |